Retatrutide+Cagrilintide 10mg

Description

⚠️ FOR RESEARCH PURPOSES ONLY — NOT FOR HUMAN CONSUMPTION

Research Background

Retatrutide triagonist and Cagrilintide amylin analogue blend for combined multi-pathway metabolic research.

All research summaries are for informational purposes only and do not constitute medical claims. Vexar Lab compounds are not approved for human use.

Compound Data

• CAS Number: Blend
• Molecular Formula: Combination lyophilisate
• Molecular Weight: N/A
• Sequence / Structure: Retatrutide 5mg + Cagrilintide 5mg
• Appearance: White lyophilised powder
• Solubility: Water soluble

Purity & Testing

• Purity: ≥99% HPLC-UV (individual)
• Analysis: HPLC-UV
• Mass Confirmation: ESI-MS

Storage & Handling

• Sealed: −20°C
• Reconstituted: 4°C use within 28 days
• Stability: 24 months

Reconstitution Guide

Reconstitute with sterile water. Store at 4°C.

For research purposes only — not for human consumption.

Ordering

Minimum order £300. £45 flat worldwide shipping. Custom vial labelling available (+3 weeks lead time). Unlabelled orders dispatch within 1 week.

Legal Disclaimer

FOR RESEARCH USE ONLY. Not for human consumption. Not a medicine. Not intended to diagnose, treat, cure or prevent any disease or medical condition. By purchasing you confirm you are a qualified research professional using this compound for legitimate in-vitro laboratory research purposes only. Vexar Lab accepts no liability for misuse.